Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

Understanding regional variation in medicare expenditures for initial episodes of prostate cancer care.

Wang SY, Wang R, Yu JB, Ma X, Xu X, Kim SP, Soulos PR, Saraf A, Gross CP.

Med Care. 2014 Aug;52(8):680-7. doi: 10.1097/MLR.0000000000000158.

PMID:
25023913
[PubMed - in process]
2.

Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.

Kim SP, Gross CP, Nguyen PL, Smaldone MC, Shah ND, Karnes RJ, Thompson RH, Han LC, Yu JB, Trinh QD, Ziegenfuss JY, Sun M, Tilburt JC.

Med Care. 2014 Jul;52(7):579-85. doi: 10.1097/MLR.0000000000000155.

PMID:
24926704
[PubMed - in process]
3.

Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009.

Yang DX, Gross CP, Soulos PR, Yu JB.

Cancer. 2014 Jun 3. doi: 10.1002/cncr.28794. [Epub ahead of print]

PMID:
24894740
[PubMed - as supplied by publisher]
4.

Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.

Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB.

Am J Clin Oncol. 2014 May 29. [Epub ahead of print]

PMID:
24879475
[PubMed - as supplied by publisher]
5.

The global cancer divide: relationships between national healthcare resources and cancer outcomes in high-income vs. middle- and low-income countries.

Batouli A, Jahanshahi P, Gross CP, Makarov DV, Yu JB.

J Epidemiol Glob Health. 2014 Jun;4(2):115-24. doi: 10.1016/j.jegh.2013.10.004. Epub 2013 Dec 28.

PMID:
24857179
[PubMed - in process]
6.

For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery.

Sen S, Soulos PR, Herrin J, Roberts KB, Yu JB, Lesnikoski BA, Ross JS, Krumholz HM, Gross CP.

Surgery. 2014 May;155(5):776-88. doi: 10.1016/j.surg.2013.12.009. Epub 2013 Dec 15.

PMID:
24787104
[PubMed - in process]
7.

Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.

Lester-Coll NH, Dosoretz AP, Yu JB.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):563-8. doi: 10.1016/j.ijrobp.2014.03.001. Epub 2014 Apr 18.

PMID:
24751412
[PubMed - in process]
8.

Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors.

Wang C, Roberts KB, Bindra RS, Chiang VL, Yu JB.

Pediatr Neurol. 2014 Jun;50(6):549-56. doi: 10.1016/j.pediatrneurol.2013.09.018. Epub 2014 Jan 25.

PMID:
24739378
[PubMed - in process]
9.

Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions.

Han LC, Delpe S, Shah ND, Ziegenfuss JY, Tilburt JC, Karnes RJ, Nguyen PL, Gross CP, Yu JB, Trinh QD, Sun M, Ranasinghe WK, Kim SP.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):277-83. doi: 10.1016/j.ijrobp.2014.02.001. Epub 2014 Mar 27.

PMID:
24685153
[PubMed - indexed for MEDLINE]
10.

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity.

Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP.

J Clin Oncol. 2014 Apr 20;32(12):1195-201. doi: 10.1200/JCO.2013.53.8652. Epub 2014 Mar 10.

PMID:
24616315
[PubMed - indexed for MEDLINE]
11.

Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.

Sen S, Wang SY, Soulos PR, Frick KD, Long JB, Roberts KB, Yu JB, Evans SB, Chagpar AB, Gross CP.

J Natl Cancer Inst. 2014 Mar;106(3):dju008. doi: 10.1093/jnci/dju008. Epub 2014 Mar 5.

PMID:
24598714
[PubMed - in process]
12.

Treating locally advanced disease: an analysis of very large, hilar lymph node positive non-small cell lung cancer using the National Cancer Data Base.

Moreno AC, Morgensztern D, Boffa DJ, Decker RH, Yu JB, Detterbeck FC, Wang Z, Rose MG, Kim AW.

Ann Thorac Surg. 2014 Apr;97(4):1149-55. doi: 10.1016/j.athoracsur.2013.12.045. Epub 2014 Feb 26.

PMID:
24582051
[PubMed - indexed for MEDLINE]
13.

Poorer Prognosis of African-American Patients With Mycosis Fungoides: An Analysis of the SEER Dataset, 1988 to 2008.

Nath SK, Yu JB, Wilson LD.

Clin Lymphoma Myeloma Leuk. 2014 Jan 3. pii: S2152-2650(13)00542-9. doi: 10.1016/j.clml.2013.12.018. [Epub ahead of print]

PMID:
24508350
[PubMed - as supplied by publisher]
14.

Significance of histology in determining management of lesions regrowing after radiosurgery.

Nath SK, Sheridan AD, Rauch PJ, Yu JB, Minja FJ, Vortmeyer AO, Chiang VL.

J Neurooncol. 2014 Apr;117(2):303-10. doi: 10.1007/s11060-014-1389-2. Epub 2014 Feb 7.

PMID:
24504499
[PubMed - in process]
15.

Academic and Resident Radiation Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of Life.

Lloyd S, Dosoretz AP, Yu JB, Evans SB, Decker RH.

Am J Clin Oncol. 2014 Jan 2. [Epub ahead of print]

PMID:
24390273
[PubMed - as supplied by publisher]
16.

Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.

Aneja S, Yu JB.

Semin Radiat Oncol. 2014 Jan;24(1):35-42. doi: 10.1016/j.semradonc.2013.08.004.

PMID:
24314340
[PubMed - in process]
17.

Role of stereotactic radiosurgery in patients with more than four brain metastases.

Jairam V, Chiang VL, Yu JB, Knisely JP.

CNS Oncol. 2013 Mar 1;2(2). doi: 10.2217/cns.13.4.

PMID:
24273642
[PubMed]
Free PMC Article
18.

The cost implications of prostate cancer screening in the Medicare population.

Ma X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP.

Cancer. 2014 Jan 1;120(1):96-102. doi: 10.1002/cncr.28373. Epub 2013 Oct 4.

PMID:
24122801
[PubMed - indexed for MEDLINE]
19.

Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment.

Lloyd S, Buscariollo DL, Gross CP, Makarov DV, Yu JB.

J Natl Compr Canc Netw. 2013 Aug;11(8):928-36.

PMID:
23946172
[PubMed - indexed for MEDLINE]
20.

Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.

Kim SP, Tilburt JC, Karnes RJ, Ziegenfuss JY, Han LC, Shah ND, Frank I, Smaldone MC, Gross CP, Yu JB, Trinh QD, Sun M, O'Malley RL, Nguyen PL.

Urology. 2013 Oct;82(4):807-12. doi: 10.1016/j.urology.2013.04.060. Epub 2013 Aug 1.

PMID:
23910088
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk